137 related articles for article (PubMed ID: 10980144)
21. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.
Rigau V; Sebbagh N; Olschwang S; Paraf F; Mourra N; Parc Y; Flejou JF
Arch Pathol Lab Med; 2003 Jun; 127(6):694-700. PubMed ID: 12741892
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma.
Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042
[TBL] [Abstract][Full Text] [Related]
23. [Methylation is a frequent mechanism of inactivation of the hMLH1 gene copies in sporadic colonic cancer].
Larsen CJ
Bull Cancer; 1998 Sep; 85(9):741-2. PubMed ID: 9817055
[No Abstract] [Full Text] [Related]
24. The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.
Cunningham JM; Kim CY; Christensen ER; Tester DJ; Parc Y; Burgart LJ; Halling KC; McDonnell SK; Schaid DJ; Walsh Vockley C; Kubly V; Nelson H; Michels VV; Thibodeau SN
Am J Hum Genet; 2001 Oct; 69(4):780-90. PubMed ID: 11524701
[TBL] [Abstract][Full Text] [Related]
25. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
26. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population.
Shashidharan M; Smyrk T; Lin KM; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lynch HT
Dis Colon Rectum; 1999 Jun; 42(6):722-6. PubMed ID: 10378595
[TBL] [Abstract][Full Text] [Related]
27. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours.
Ruszkiewicz A; Bennett G; Moore J; Manavis J; Rudzki B; Shen L; Suthers G
Pathology; 2002 Dec; 34(6):541-7. PubMed ID: 12555992
[TBL] [Abstract][Full Text] [Related]
28. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
[TBL] [Abstract][Full Text] [Related]
29. [Hereditary nonpolyposis colorectal cancer].
Matsukawa M; Yamamoto T; Kouda T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():189-92. PubMed ID: 14574879
[No Abstract] [Full Text] [Related]
30. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
[TBL] [Abstract][Full Text] [Related]
31. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors.
Bujalkova M; Zavodna K; Krivulcik T; Ilencikova D; Wolf B; Kovac M; Karner-Hanusch J; Heinimann K; Marra G; Jiricny J; Bartosova Z
Clin Chem; 2008 Nov; 54(11):1844-54. PubMed ID: 18772310
[TBL] [Abstract][Full Text] [Related]
32. Mismatch repair proteins and microsatellites hit clinical practice.
Stahl J
Adv Anat Pathol; 2000 Mar; 7(2):85-93. PubMed ID: 10721415
[TBL] [Abstract][Full Text] [Related]
33. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.
Bapat BV; Madlensky L; Temple LK; Hiruki T; Redston M; Baron DL; Xia L; Marcus VA; Soravia C; Mitri A; Shen W; Gryfe R; Berk T; Chodirker BN; Cohen Z; Gallinger S
Hum Genet; 1999 Feb; 104(2):167-76. PubMed ID: 10190329
[TBL] [Abstract][Full Text] [Related]
34. Differential rates of frameshift alterations in four repeat sequences of hereditary nonpolyposis colorectal cancer tumors.
Paoloni-Giacobino A; Rey-Berthod C; Couturier A; Antonarakis SE; Hutter P
Hum Genet; 2002 Sep; 111(3):284-9. PubMed ID: 12215842
[TBL] [Abstract][Full Text] [Related]
35. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
[TBL] [Abstract][Full Text] [Related]
36. Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Online.
Holmberg M; Kristo P; Chadwicks RB; Mecklin JP; Järvinen H; de la Chapelle A; Nyström-Lahti M; Peltomäki P
Hum Mutat; 1998; 11(6):482. PubMed ID: 10200055
[TBL] [Abstract][Full Text] [Related]
37. Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.
Shinto E; Baker K; Tsuda H; Mochizuki H; Ueno H; Matsubara O; Foulkes WD; Jass JR
Dis Colon Rectum; 2006 Aug; 49(8):1193-202. PubMed ID: 16773493
[TBL] [Abstract][Full Text] [Related]
38. Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer.
Bandipalliam P; Garber J; Kolodner RD; Syngal S
Gastroenterology; 2004 Mar; 126(3):936-7. PubMed ID: 14988860
[No Abstract] [Full Text] [Related]
39. Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer.
Menigatti M; Di Gregorio C; Borghi F; Sala E; Scarselli A; Pedroni M; Foroni M; Benatti P; Roncucci L; Ponz de Leon M; Percesepe A
Genes Chromosomes Cancer; 2001 Aug; 31(4):357-61. PubMed ID: 11433526
[TBL] [Abstract][Full Text] [Related]
40. Multimodal molecular screening is required to improve the sensitivity of MLH1 and MSH2 mutation analysis.
Andermann A; Thiffault I; Wong N; Gordon P; MacNamara E; Chong G; Foulkes W
J Clin Oncol; 2002 Mar; 20(6):1705-7. PubMed ID: 11896123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
